Shu Liu
Harbin Medical University(CN)Fourth Affiliated Hospital of Harbin Medical University(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Protein Structure and Dynamics, Mitochondrial Function and Pathology, Diabetes Treatment and Management, Chemical Synthesis and Analysis
Most-Cited Works
- → Zebrafish Models for Cancer(2011)170 cited
- → Nuclear Factor Kappa B Signaling Initiates Early Differentiation of Neural Stem Cells(2011)91 cited
- → Identification of a cAMP-response Element in the Regulator of G-protein Signaling-2 (RGS2) Promoter as a Key Cis-regulatory Element for RGS2 Transcriptional Regulation by Angiotensin II in Cultured Vascular Smooth Muscles(2011)59 cited
- → Application of Consensus Scoring and Principal Component Analysis for Virtual Screening against β-Secretase (BACE-1)(2012)49 cited
- → Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation(2020)48 cited
- → Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE)(2012)37 cited
- → Optimization of Non-ATP Competitive CDK/Cyclin Groove Inhibitors through REPLACE-Mediated Fragment Assembly(2013)21 cited
- → Superimposing the 27 crystal protein/inhibitor complexes of β-secretase to calculate the binding affinities by the linear interaction energy method(2010)9 cited
- → Efficacy and safety of metformin and sitagliptin‐based dual and triple therapy in elderly Chinese patients with type 2 diabetes: Subgroup analysis of STRATEGY study(2020)8 cited
- → BCR-ABL tyrosine kinase inhibitor pharmacophore model derived from a series of phenylaminopyrimidine-based (PAP) derivatives(2013)8 cited